Evaluation of Minimal Residual Disease in Acute Myeloid Leukemia with NPM1 Marker

Evaluation of Minimal Residual Disease in Acute Myeloid Leukemia with NPM1 Marker

Background: Minimal residual disease (MRD) tests provide early identification of hematologic relapse and timely management of acute myeloid leukemia (AML) patients. Approximately, 50% of AML patients do not have clonal chromosomal aberrations and categorize as a cytogenetically normal acute myeloid...

Full description

Bibliographic Details
Main Authors: Nasrin Alizad Ghandforoush, Bahram Chahardouli, Shahrbano Rostami, Habibeh Ghadimi, Ali Ghasemi, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Fatemeh Nadali
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2016-06-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Acute myeloid leukemia
MRD
NPM1 mutation
Q-RT-PCR
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/497

Internet

https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/497

Similar Items